Where it comes from
- Made in
- Adrenal medulla, striatum and spinal cord
- Sent out by
- With the enkephalins
- Acts on
- Opioid receptors
What it does
- An active opioid in its own right, released from striatal tissue alongside the heptapeptide and inactivated as fast 1
- Mapped with antisera raised against its Arg-Gly-Leu tail, which is how its nerves can be told from met-enkephalin’s 2
- Trimmed to met-enkephalin in tissue, so the amount found depends on how quickly it is cut
In medicine
- No medicine copies it or blocks it, and no clinical laboratory measures it
- Its use is as a read-out of processing rather than of opioid tone: the ratio of octapeptide to pentapeptide differs between adrenal, striatum and gut, which reports on the cutting enzymes of each tissue 1
Beyond the body’s own use
- Nothing is in trials, and no analogue of it has been given to a person
- Its one distinctive finding is anatomical: antisera to the octapeptide label a set of nerves in lung and pancreas that run with VIP rather than with the classic enkephalin pathways 2
- What is unknown is whether the extension does more than slow its breakdown. Oxidising its methionine turns it into a substrate for neutrophil elastase, so inflamed tissue can destroy it by a route the ordinary peptidases do not use 3
Sources
- Patey et al., Release and rapid inactivation of the heptapeptide and octapeptide enkephalins from rat striatum, Life Sciences 1983
- Shimosegawa et al., Met-enkephalin-Arg-Gly-Leu nerves in guinea-pig and rat lungs, Neuroscience 1990
- Watorek et al., The action of neutrophil elastase on intact and oxidised Met-enkephalin-Arg-Gly-Leu, Biochemical and Biophysical Research Communications 1987
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.